ABC2-Funded Research Featured in Scientific American

Brain cancer research funded by Accelerate Brain Cancer Cure is featured in Scientific American today.

The research involves a multi-center clinical study using new exosomal diagnostic tests developed by New York City-based Exosome Diagnostics to identify a genetic mutation found exclusively in glioma, the most common form of brain cancer.  

Brain tumor cells shed micro-vesicles, called exosomes, into cerebral spinal fluid, blood, and urine. This new method of testing could potentially detect and monitor the progression of a wide variety of cancers and eliminate the need for painful and sometimes life-threatening biopsies. 

Read the full article in Scientific American.

Learn more about the exosome project and other brain cancer research funded by Accelerate Brain Cancer Cure.

Main Image Credit: 
Scientific American
Newsletter Issue: 
Share |
March 19, 2022 09:35 PM
Proceeds from the Florida Brain Cancer 5k support this ongoing partnership.
March 18, 2022 04:41 PM
ABC2 is working with Matt de Silva, co-founder of Notable Labs, to advance personalized treatments for brain cancer.

Join us in our fight for a cure!